Question

I am a breastfeeding mother and i want to know if it is safe to use Colestiramina? Is Colestiramina safe for nursing mother and child? Does Colestiramina extracts into breast milk? Does Colestiramina has any long term or short term side effects on infants? Can Colestiramina influence milk supply or can Colestiramina decrease milk supply in lactating mothers?

Colestiramina lactation summary

Colestiramina is safe in breastfeeding
  • DrLact safety Score for Colestiramina is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of Colestiramina is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that Colestiramina does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of Colestiramina safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Colestiramina usage in lactation

It is not orally absorbed. It is not secreted into breast milk. Prolonged use may be a cause of hydrosoluble vitamin deficiency in the mother.

Answer by DrLact: About Colestiramina usage in lactation

Colestiramina is a nonabsorbable resin. Because it does not enter the mother's bloodstream, it will not reach the infant via breastmilk. It is acceptable for use during lactation.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.